scholarly journals INTRAVENOUS FUROSEMIDE IN THE AMBULATORY SETTING FOR THE MANAGEMENT OF A COMPLEX HEART FAILURE PATIENT

2017 ◽  
Vol 69 (11) ◽  
pp. 2108
Author(s):  
Cassandra D. Benge ◽  
Jessica Wallace ◽  
Henry Ooi ◽  
Deborah Cole ◽  
William Stone
2019 ◽  
Vol 5 (1 (P)) ◽  
pp. 34
Author(s):  
Budi Yuli Setianto

Heart failure (HF) leads to frequent hospitalizations. The presence of re-hospitalization risk among patientshospitalized for heart failure is important, especially hemodynamic instability and neurohormonal over activation. ARNI is needed to restore the balance of neurohormonal system in HF. PARADIGM-HF study provide insight on long term benefit of ARNI (i.e. sacubitril/valsartan) in ambulatory setting. How is the evidence of ARNI use for in hospitalization phase of HF? PIONEER and TRANSITION showed that initiation of sacubitril/valsartan shortly after an ADHF event is feasible and well tolerated. In-hospital initiation of sacubitril/valsartan is associated with early and sustained improvements in biomarkers of cardiac wall stress and myocardial injury, indicating pathophysiological benefits in a wide range of HFrEF patients.


2004 ◽  
Vol 17 (3) ◽  
pp. 150-157 ◽  
Author(s):  
Judith C. Clark ◽  
Virginia M. Lan

2018 ◽  
Vol 37 (6) ◽  
pp. 491-496
Author(s):  
Gustavo Rodrigues ◽  
António Tralhão ◽  
Carlos Aguiar ◽  
Pedro Freitas ◽  
António Ventosa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document